Anuh Pharma Ltd received EDQM approval for CEP of Allopurinol API

Anuh Pharma Limited has received approval from EDQM for CEP of Allopurinol API which is used to treat Gout and High Uric Acid Levels.

Shares of ANUH PHARMA LTD. was last trading in BSE at Rs. 203.10 as compared to the previous close of Rs. 205.60. The total number of shares traded during the day was 20530 in over 357 trades.

The stock hit an intraday high of Rs. 207.90 and intraday low of 202.20. The net turnover during the day was Rs. 4204972.00.

Source : Equity Bulls

Keywords

ANUHPHARMA INE489G01022 Pharmaceuticals Approval EDQM CEPfoAllopurino API Gout HighUricAcid